Form 4: Cartesian Therapeutics Insider Elizabeth Hoge Reports Conversion of Preferred Stock to Common Stock

Elizabeth Hoge, a director and 10% owner of Cartesian Therapeutics, reported the conversion of Series A Preferred Stock into Common Stock following stockholder approval.

Summary

• On April 8, 2024, Elizabeth Hoge reported the conversion of Series A Non-Voting Convertible Preferred Stock into Common Stock of Cartesian Therapeutics, Inc.
• The conversion occurred following stockholder approval, with each share of Series A Preferred Stock converting into 33-1/3 shares of Common Stock, subject to certain limitations.
• After the conversion, Elizabeth Hoge indirectly owns 3,036,887 shares of Common Stock as trustee and 506,377 shares by spouse.
• Murat Kalayoglu is authorized to file forms on behalf of Elizabeth Hoge and Seven One Eight Three Four Irrevocable Trust.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing a conversion of stock. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Positives

• The conversion of preferred stock to common stock simplifies the capital structure of Cartesian Therapeutics.

Risks

• The conversion is subject to limitations, including a restriction that prevents a holder from owning more than 19.9% of the Common Stock after conversion.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the conversion of preferred stock to common stock could have implications for the company's capital structure and future financing activities.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates a change in the ownership structure of Cartesian Therapeutics, which may be of interest to investors.

Stakeholder Impact

• The conversion of preferred stock to common stock may impact the ownership structure and voting rights of existing shareholders.

Key Dates